Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ENVX | Common Stock | Award | +157K | 157K | Jul 14, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ENVX | Stock Option (Right to Buy) | Award | +55.4K | 55.4K | Jul 14, 2021 | Common Stock | 55.4K | $0.06 | Direct | F1, F2, F3 | |||
transaction | ENVX | Stock Option (Right to Buy) | Award | +46.2K | 46.2K | Jul 14, 2021 | Common Stock | 46.2K | $9.26 | Direct | F1, F4, F5 | |||
transaction | ENVX | Stock Option (Right to Buy) | Award | +28.4K | 28.4K | Jul 14, 2021 | Common Stock | 28.4K | $6.26 | Direct | F1, F6, F7 |
Id | Content |
---|---|
F1 | Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation. |
F2 | The shares subject to the option are immediately exercisable. 1/4th of the shares subject to the option vest on the one year anniversary of the vesting commencement date, January 4, 2021, and 1/48th of the shares subject to the option will vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date. |
F3 | Received in exchange for a stock option to purchase 300,000 shares of Legacy Enovix Common Stock. |
F4 | The shares subject to the option are immediately exercisable and vest in 60 equal monthly installments beginning on the vesting commencement date, April 18, 2021, subject to Reporting Person's continuous service through each such vesting date. |
F5 | Received in exchange for a stock option to purchase 250,000 shares of Legacy Enovix Common Stock. |
F6 | The shares subject to the option are immediately exercisable. 1/120th of the shares subject to the option vest monthly over 4 years beginning on the vesting commencement date, April 18, 2021, and 1/20th of the shares subject to the option vest monthly thereafter over the next year, subject to Reporting Person's continuous service through each such vesting date. |
F7 | Received in exchange for a stock option to purchase 153,900 shares of Legacy Enovix Common Stock. |
Chief Legal Officer, General Counsel and Secretary